Glass et al., 1975 - Google Patents
Use of cell separation and short-term culture techniques to study erythroid cell developmentGlass et al., 1975
View HTML- Document ID
- 13310831953188044764
- Author
- Glass J
- Lavidor L
- Robinson S
- Publication year
External Links
Snippet
Cell populations highly enriched for the different stages of erythroid cell maturation were obtained by three sequential operations: harvesting of erythroid cells after induction of erythroid hyperplasia in the spleens of mice, elimination of the more mature erythrocytes by …
- 210000004027 cells 0 title abstract description 127
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0289896B1 (en) | A simplified method for the preparation of human lymphokine activated killer cells | |
Spangrude et al. | Resting and activated subsets of mouse multipotent hematopoietic stem cells. | |
Long et al. | Immature megakaryocytes in the mouse: physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor | |
US5766944A (en) | T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments | |
Ishizaka et al. | Development of rat mast cells in vitro: I. Differentiation of mast cells from thymus cells | |
Nijhof et al. | Isolation and characterization of the erythroid progenitor cell: CFU-E. | |
Donnelly et al. | Functional activity of murine CD34+ and CD34− hematopoietic stem cell populations | |
Glass et al. | Use of cell separation and short-term culture techniques to study erythroid cell development | |
Gibson et al. | Isolation of colonic crypts that maintain structural and metabolic viability in vitro | |
Tomer et al. | Purification of human megakaryocytes by fluorescence-activated cell sorting | |
Gladwin et al. | Identification of mRNA for PDGF B‐chain in human megakaryocytes isolated using a novel immunomagnetic separation method | |
US20050118142A1 (en) | Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd | |
WO1994025571A1 (en) | Human erythroid progenitor cell population | |
Mazur et al. | Isolation of large numbers of enriched human megakaryocytes from liquid cultures of normal peripheral blood progenitor cells | |
NOGA et al. | Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow | |
CA2154787A1 (en) | Selective cell proliferation | |
Metcalf et al. | The nature of the cells generating B‐lymphocyte colonies in vitro | |
Sutherland et al. | Short‐term cultures of mouse marrow cells separated by velocity sedimentation | |
Nakeff et al. | Separation of megakaryocytes from mouse bone marrow by density gradient centrifugation | |
Hopper et al. | The differentiation of T-lymphocytes: III. The behaviour of subpopulations of mouse thymus cells in short-term cell culture | |
Tiso et al. | Spontaneous apoptosis in human thymocytes | |
Reimann et al. | Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markers. | |
Gluckman | Umbilical cord blood biology and transplantation | |
Tompkins et al. | Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2. | |
Takehara et al. | Two-dimensional flow cytometric analysis of intrahepatic lymphocyte subsets from patients with chronic hepatitis |